Dumont & Blake Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-189
| Closed | -$203K | – | 213 |
|
|
2025
Q4 | $203K | Buy |
+189
| New | +$181K | 0.05% | 192 |
|
|
2022
Q3 | – | Sell |
-7,550
| Closed | -$2.45M | – | 193 |
|
|
2022
Q2 | $2.45M | Hold |
7,550
| – | – | 0.8% | 29 |
|
|
2022
Q1 | $2.16M | Hold |
7,550
| – | – | 0.59% | 44 |
|
|
2021
Q4 | $2.08M | Hold |
7,550
| – | – | 0.54% | 49 |
|
|
2021
Q3 | $1.74M | Hold |
7,550
| – | – | 0.5% | 55 |
|
|
2021
Q2 | $1.73M | Hold |
7,550
| – | – | 0.49% | 60 |
|
|
2021
Q1 | $1.41M | Hold |
7,550
| – | – | 0.43% | 69 |
|
|
2020
Q4 | $1.27M | Hold |
7,550
| – | – | 0.44% | 66 |
|
|
2020
Q3 | $1.12M | Hold |
7,550
| – | – | 0.42% | 71 |
|
|
2020
Q2 | $1.24M | Hold |
7,550
| – | – | 0.52% | 55 |
|
|
2020
Q1 | $1.05M | Hold |
7,550
| – | – | 0.54% | 54 |
|
|
2019
Q4 | $992K | Hold |
7,550
| – | – | 0.39% | 79 |
|
|
2019
Q3 | $844K | Hold |
7,550
| – | – | 0.36% | 87 |
|
|
2019
Q2 | $836K | Hold |
7,550
| – | – | 0.35% | 90 |
|
|
2019
Q1 | $980K | Hold |
7,550
| – | – | 0.41% | 77 |
|
|
2018
Q4 | $874K | Hold |
7,550
| – | – | 0.41% | 79 |
|
|
2018
Q3 | $810K | Hold |
7,550
| – | – | 0.32% | 104 |
|
|
2018
Q2 | $644K | Hold |
7,550
| – | – | 0.27% | 116 |
|
|
2018
Q1 | $584K | Hold |
7,550
| – | – | 0.25% | 115 |
|
|
2017
Q4 | $638K | Hold |
7,550
| – | – | 0.26% | 117 |
|
|
2017
Q3 | $646K | Hold |
7,550
| – | – | 0.28% | 117 |
|
|
2017
Q2 | $621K | Hold |
7,550
| – | – | 0.28% | 115 |
|
|
2017
Q1 | $635K | Hold |
7,550
| – | – | 0.29% | 117 |
|
|
2016
Q4 | $555K | Hold |
7,550
| – | – | 0.26% | 121 |
|
|
2016
Q3 | $606K | Hold |
7,550
| – | – | 0.3% | 111 |
|
|
2016
Q2 | $595K | Hold |
7,550
| – | – | 0.3% | 108 |
|
|
2016
Q1 | $544K | Hold |
7,550
| – | – | 0.28% | 112 |
|
|
2015
Q4 | $636K | Hold |
7,550
| – | – | 0.32% | 107 |
|
|
2015
Q3 | $632K | Hold |
7,550
| – | – | 0.34% | 102 |
|
|
2015
Q2 | $630K | Hold |
7,550
| – | – | 0.31% | 112 |
|
|
2015
Q1 | $549K | Hold |
7,550
| – | – | 0.27% | 117 |
|
|
2014
Q4 | $521K | Hold |
7,550
| – | – | 0.26% | 117 |
|
|
2014
Q3 | $490K | Hold |
7,550
| – | – | 0.25% | 120 |
|
|
2014
Q2 | $469K | Hold |
7,550
| – | – | 0.24% | 122 |
|
|
2014
Q1 | $444K | Hold |
7,550
| – | – | 0.23% | 120 |
|
|
2013
Q4 | $385K | Hold |
7,550
| – | – | 0.2% | 122 |
|
|
2013
Q3 | $380K | Hold |
7,550
| – | – | 0.18% | 127 |
|
|
2013
Q2 | $371K | Buy |
+7,550
| New | +$411K | 0.22% | 106 |
|
Other funds holding LLY
VCM
VPM
Dumont & Blake Investment Advisors's LLY Position: Q1 2026 in Review
Dumont & Blake Investment Advisors sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 189 shares — an estimated $203K sold.
Dumont & Blake Investment Advisors first reported a position in LLY in Q2 2013 and held it in 38 quarters. The position peaked at $2.45M in Q2 2022. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Dumont & Blake Investment Advisors reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Dumont & Blake Investment Advisors sold 189 Eli Lilly shares in Q1 2026, an estimated $203K.
- Dumont & Blake Investment Advisors first reported a position in Eli Lilly in Q2 2013 and held it in 38 quarters.
- Dumont & Blake Investment Advisors's Eli Lilly position peaked at $2.45M in Q2 2022.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.